Sickle cell - Weeknote #7

A screenshot of a document that with two headlines reading "sickle cell digital discovery" in bold and "better acure painful sickle cell care" in standard font
Our first draft of our report

17-21 October 2022

What have we been up to this week?

This week:

  • We drafted the first iteration of our discovery report!

  • We ran the last of our user research interviews with people with lived experience of sickle cell

  • We did a lot more analysis and synthesis of our user research data and identified a set of important observations

  • We restarted our digital and technology landscape review

The first iteration of our discovery report

We have written the first iteration of our discovery report. It covers:

  • Introduction: what we’re trying to do

  • Our methodology: what we’ve done so far

  • Our user research: what we have observed

  • Further observations

  • Our plan: what we’re going to do next

  • What further iterations of this report are likely to include

This is the very first version of what we have learnt so far, and we expect it to develop and change over the remainder of the discovery. We are sharing it openly and early, so that you can help review and shape the direction this work goes in.

You can read the first draft here. How well does what we have observed resonate with your experience? What are we missing? Has anything surprised you?

We would love to hear what you think.

To let us know, email [email protected]

Our user research interviews

On Monday, we spoke to 3 more people with sickle cell disease who shared their experiences of managing sickle cell and sickle cell crises with us. We have been utterly blown away by people’s willingness to participate in this research, and as we’ve worked on theming and summarising what we’ve learnt from speaking to you all, we are struck once again by how invaluable your openness, time and insight has been. Thank you.

What we have observed through our user research

Everything we have learnt so far has led us to a number of observations about the experience people have when they are having a sickle cell crisis. There are 7 which we feel are especially relevant in the moment of crisis:

  1. Sickle cell patients often have additional needs which are not picked up on by healthcare professionals in the moment of crisis, meaning they must stay alert and monitor the treatment they are receiving.

  2. Care plans are used inconsistently, and vary widely in their format and in how they are interpreted by patients and healthcare professionals, meaning they do not currently result in consistently good care.

  3. Tracking the medication a sickle cell patient is taking is an arduous, daily task, and it becomes particularly difficult in the context of a painful crisis.

  4. The way that A&E works is not designed for and does not meet the needs of sickle cell patients in crisis, leading to poor, painful experiences and a strong desire to avoid attending.

  5. There is a stark imbalance between the level of mistrust people with sickle cell face, and the simultaneous pressure on them to manage much of their own care.

  6. There is a persistent lack of communication and collaboration across healthcare professionals in hospitals and across different settings, which results in an administrative burden for people with sickle cell, and contributes to poor experience and treatment when in crisis.

  7. Different people would like a different level of input from healthcare professionals in managing their condition day to day, and when they are in crisis.

These observations will inform the remainder of our discovery work, as we now turn our attention to exploring digital interventions which could help to address these challenges.

Digital and technology landscape review

If you’ve been following our work, you may remember that we intended to kick this review off sooner, but then made a decision to wait so that it could be informed by what we learnt from speaking to people with sickle cell. That being done, we have decided to start by focusing on developing our understanding of what is available currently:

  • That is specific to sickle cell disease

  • In the space of digital care plans

  • To help with medication tracking

  • To help with pain management

  • In the realms of wearable technology

We will explore these areas initially, and then we will decide whether to pursue them further or change our focus. We’ll keep you posted!

The Public Digital team with the NHS Race and Health Observatory

Working boldly in the open to kickstart the redesign of sickle cell pathways

View client story
image003.png

Transforming services to better meet the needs of children in Nottinghamshire

View client story
Exterior of Walton Centre

Improving clinical safety and cost efficiencies: the Walton Centre

View client story